tezepelumab

Ukraine

Drugs containing this active substance

TEZPYR

The drug is intended as add-on maintenance therapy for adults and children aged 12 years and older with severe asthma that is not adequately controlled despite the use of high-dose inhaled corticosteroids in combination with other maintenance treatments.

Form: solution for injection

Active substance	Dosage
tezepelumab	210 mg/1.91 ml (110 mg/ml)

ATC: R03DX11

Manufacturer: Amgen Manufacturing Limited (AML) (Prefilled syringe: drug substance manufacturing, primary packaging, quality control testing; Prefilled pen: drug substance manufacturing, primary packaging, quality control testing)